WallStreetZen

NYSE: DHR
Danaher Corp Earnings & Revenue

OverviewForecastEarnings
DividendOwnership

DHR past earnings growth

How has DHR's earnings growth performed historically?
Company
59.44%
Industry
179.22%
Market
104.53%
DHR's earnings have grown slower (17.18% per year) than the US Diagnostics & Research industry average (64.74%)
Performance
DHR's earnings have grown slower (17.18% per year) than the US market average (31.1%)
Performance
DHR's earnings growth is accelerating - its growth over the last year (59.44%) is above its 5-year compound annual rate (17.18%)
Performance

DHR past revenue growth

How has DHR's revenue growth performed historically?
Company
37.63%
Industry
39.89%
Market
41.42%
DHR's revenue has grown slower (11.05% per year) than the US Diagnostics & Research industry average (18.88%)
Performance
DHR's revenue has grown slower (11.05% per year) than the US market average (19.51%)
Performance
DHR's revenue growth is accelerating - its growth over the last year (37.63%) is above its 5-year compound annual rate (11.05%)
Performance

DHR earnings and revenue history

Current Revenue
$28.1B
Current Earnings
$5.7B
Current Profit Margin
20.4%
DHR's has demonstrated consistent long-term earnings growth over the past 10 years (158.71%)
Performance

DHR Return on equity

Current Company
13.8%
Current Industry
16.8%
Current Market
21.6%
DHR's Return on Equity (13.8%) shows a company that is not efficient at transforming shareholder equity into returns
Performance

DHR Return on assets

Current Company
7.3%
Current Industry
5.8%
DHR is generating lower Return on Assets (7.3%) than the US Diagnostics & Research industry average (8.62%)
Performance

DHR Return on capital employed

Current Company
9.83%
Current Industry
9.1%
DHR has gotten more efficient at generating Return on Capital (9.83%) compared to 3 years ago (7.8%)
Performance

Danaher Corp Earnings & Revenue FAQ

What were DHR's earnings last quarter?

On Invalid Date, Danaher Corp (NYSE: DHR) reported Q3 2021 earnings per share (EPS) of $1.56, up 32.2% year over year. Total Danaher Corp earnings for the quarter were $1.12 billion. In the same quarter last year, Danaher Corp's earnings per share (EPS) was $1.18.

What was DHR's earnings growth in the past year?

As of Q4 2021, Danaher Corp's earnings has grown 59.44% year over year. This is 119.78 percentage points lower than the US Diagnostics & Research industry earnings growth rate of 179.22%. Danaher Corp's earnings in the past year totalled $5.72 billion.

What was DHR's revenue last quarter?

On Invalid Date, Danaher Corp (NYSE: DHR) reported Q3 2021 revenue of $7.23 billion up 22.86% year over year. In the same quarter last year, Danaher Corp's revenue was $5.88 billion.

What was DHR's revenue growth in the past year?

As of Q4 2021, Danaher Corp's revenue has grown 37.63% year over year. This is 2.26 percentage points lower than the US Diagnostics & Research industry revenue growth rate of 39.89%. Danaher Corp's revenue in the past year totalled $28.07 billion.
©2021 WallStreetZen
Company
AboutBlogPlansPrivacy PolicyTerms of ServiceCancellation & RefundsContact
Stocks
Stock ScreenerStock ForecastHighest Earnings StocksBest Dividend Paying StocksStatisticsTrending Stocks
Analysts
Top Performing Analysts
Social
TwitterYouTube
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.